Toll-like receptor 7/8-matured RNA-transduced dendritic cells as post-remission therapy in acute myeloid leukaemia: results of a phase I trial
/in Acute Leukemia, Dendritic Cells, International Publications /von 2020-03-03 / Clin Transl Immunology 2020;9(3):e1117Can Dendritic Cell Vaccination Prevent Leukemia Relapse?
/in Acute Leukemia, Dendritic Cells, International Publications /von 2019-06-22 / Cancers (Basel) 2019 Jun;11(6)Dendritic Cell-Based Immunotherapy of Acute Myeloid Leukemia
/in Acute Leukemia, Dendritic Cells, International Publications /von 2019-04-27 / J Clin Med 2019 Apr;8(5)Hypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell/AML vaccine
/in Acute Leukemia, Dendritic Cells, International Publications /von 2019-03-03 / Br. J. Haematol. 2019 May;185(4):679-690Maintenance of long remission in adult T-cell leukemia by Tax-targeted vaccine: A hope for disease-preventive therapy
/in Acute Leukemia, Dendritic Cells, International Publications, Malignant Lymphoma /von 2019-02-19 / Cancer Sci. 2019 Mar;110(3):849-857Immunotherapy in acute myeloid leukemia and myelodysplastic syndromes: The dawn of a new era?
/in Acute Leukemia, Dendritic Cells, International Publications /von 2018-12-05 / Blood Rev. 2019 03;34:67-83A novel allogeneic off-the-shelf dendritic cell vaccine for post-remission treatment of elderly patients with acute myeloid leukemia
/in Acute Leukemia, Dendritic Cells, International Publications /von 2018-07-23 / Cancer Immunol. Immunother. 2018 Oct;67(10):1505-1518Anti-cancer vaccine therapy for hematologic malignancies: An evolving era
/in Acute Leukemia, Checkpoint-Inhibitors, Chronic Leukemia, Dendritic Cells, International Publications /von 2018-02-15 / Blood Rev. 2018 Jul;32(4):312-325Efficacy of intracellular immune checkpoint-silenced DC vaccine
/in Acute Leukemia, Dendritic Cells, International Publications /von 2018-02-08 / JCI Insight 2018 Feb;3(3)IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de